Superior Planning, LLC’s Novo Nordisk NVO Stock Holding History

Superior Planning, LLC’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$5.53K	Buy	+146	New	+$6.73K	﹤0.01%	1162

Other funds holding NVO

Loomis, Sayles & Company Boston, Massachusetts $77.1B AUM 11.99% 1-Year Est. Return

Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return

Capital International Investors Los Angeles, California $483B AUM 27.72% 1-Year Est. Return

Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

Everett Harris & Co Los Angeles, California $8.46B AUM 13.48% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $142B AUM 43.93% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return

Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Superior Planning, LLC's NVO Position: Q3 2026 in Review

Superior Planning, LLC opened a new position in Novo Nordisk (NVO) in Q3 2026: 146 shares worth $5.53K. The stake represents ﹤0.01% of the portfolio and ranks #1162 among its holdings.

923 funds tracked by Wall St. Rank hold NVO as of Q3 2026.

Superior Planning, LLC held 146 shares of Novo Nordisk worth $5.53K as of Q3 2026.
Novo Nordisk was a new Superior Planning, LLC position in Q3 2026.
Novo Nordisk made up ﹤0.01% of Superior Planning, LLC's portfolio in Q3 2026, its #1162 holding.
923 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2026.

Based on Superior Planning, LLC's 13F filing for Q3 2026, filed 12 Nov 2026.